About type 2 diabetes

Type 2 diabetes is a metabolic disorder characterized by hyperglycemia resulting from inadequate insulin secretion or insulin resistance. The most common form of diabetes, it represents 90% of all cases. Often referred to as a pandemic, it is estimated that over 400 million people worldwide are affected by diabetes, with management costs exceeding $800 billion annually.


[1] White JR Jr. A brief history of the development of diabetes medications. Diabetes.
[2] American Diabetes Association (ADA). Standards of care in diabetes—2015. Diabetes Care. 2015;38 Suppl:S4.
[3] Ibid.
[4] Pollack MF, Purayidathil FW, Bolge SC, Williams SA. Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract. 2010;87:204-10.
[5] Karter AJ, Parker MM, Moffet HH, Ahmed AT, Schmittdiel JA, Selby JV. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res. 2009;44:1640–1661.
[6] Guillausseau P-J. Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes: a survey in general practice. Diabetes Metab. 2003;29:79–81.
[7] Garcia-Perez LE, Alvarez M, Dilla T, Gil-Guillen V, Orozco-Beltran D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013;4:175-94.
[8] Global Report on Diabetes. World Health Organization, 2016
[9] ADA. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033-46.
[10] Fu H, Curtis BH, Xie W, Festa A, et al. Frequency and causes of hospitalization in older compared to younger adults with type 2 diabetes in the United States: A retrospective, claims-based analysis. J Diabetes Complications. 2014;28:477-81.
[11] IDF. Global diabetes plan: 2011-2021.
[12] Astrup A, Finer N. Redefining type 2 diabetes: ‘Diabesity’ or ‘obesity-dependent diabetes mellitus’? Obes Rev. 2000;1:57-9.